Complete case analysis for youth reported utility derived from the CHU-9D questionnaire is presented in Table 2. Loss to follow up is reported in Appendix 3. For the BlueIce arm loss to follow up was 32 % at 12 weeks and an additional 5 % at 6 months, in the usual care arm loss ...